| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 09/21/2000 | WO2000021560A9 Flt4 (VEGFR-3) AS A TARGET FOR TUMOR IMAGING AND ANTI-TUMOR THERAPY |
| 09/21/2000 | DE19911329A1 Humantherapeutisch anwendbares Radioimmunkonjugat und Verfahren zu seiner Herstellung Human Therapeutic applicable radioimmunoconjugate and process for its preparation |
| 09/21/2000 | CA2369319A1 Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators |
| 09/20/2000 | EP0600992B1 Use of gentisic acid or gentisyl alcohol for stabilising radiolabeled peptides and proteins |
| 09/20/2000 | EP0504327B1 Therapeutic uses of the hypervariable region of monoclonal antibody m195 and constructs thereof |
| 09/20/2000 | CN1056505C Radiological imaging method |
| 09/19/2000 | US6121426 Fibrin binding domain polypeptides and uses and methods of producing same |
| 09/19/2000 | US6121305 5,5'-dihydroxy-4,4'-bipyrazole compounds of given formula; free radical scavenger; use to treat cerebral ischemia, heart disease, carcinoma, aging, inflammation or digestive system disease, or in detection of an active oxygen or free radicals |
| 09/19/2000 | US6120768 Dota-biotin derivatives |
| 09/19/2000 | US6120540 Radio prosthesis |
| 09/19/2000 | CA2266298A1 Synthesis and evaluation of two technetium-99m-labeled peptidic 2-nitroimidazoles for imaging hypoxia |
| 09/19/2000 | CA2266233A1 A novel n-formylpeptide analogue: a potential inflammation and infection imaging agent |
| 09/14/2000 | WO2000054284A1 Radioactive microsphere and method for preparation thereof |
| 09/14/2000 | WO2000053236A2 Methods and compositions for targeted drug delivery |
| 09/14/2000 | WO2000053234A1 Lipid soluble radioactive metal chelates for tumor therapy |
| 09/14/2000 | WO2000053232A1 Matriptase, a serine protease and its applications |
| 09/14/2000 | WO2000018439A3 Use of neoangiogenesis markers for diagnosing and treating tumours by therapy |
| 09/14/2000 | DE19908712A1 Verfahren zur Herstellung eines ·1··8·F-markierten Glykosylierungsreagenz sowie ·1··8·F-Glykosylierungsreagenz und dessen Verwendung A process for producing a 1 ·· · 8 · F-labeled Glykosylierungsreagenz and ·· · 1 8 · F Glykosylierungsreagenz and its use |
| 09/14/2000 | CA2366593A1 Lipid soluble radioactive metal chelates for tumor therapy |
| 09/14/2000 | CA2365354A1 Methods and compositions for targeted drug delivery |
| 09/14/2000 | CA2364455A1 Radioactive microsphere and method for preparation thereof |
| 09/14/2000 | CA2362670A1 Matriptase, a serine protease and its applications |
| 09/13/2000 | EP1034797A2 Process for the manufacture of an 18F-labelled glycosylation reagent as well as 18F-glycosylation reagent and its use |
| 09/13/2000 | EP1033972A1 Drug delivery system with two-step targeting |
| 09/13/2000 | CN1265924A Process for preparing iodine-125 seeds source carrier bar |
| 09/12/2000 | US6117991 Plasmid pav2-htsh-beta on deposit as atcc 75505; for recombinant production, diagnosis and therapy of human thyroid cancer; anticarcinogenic agents |
| 09/12/2000 | US6117855 Use of a NK-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent |
| 09/12/2000 | US6117413 Radionuclide-binding compound, a radionuclide delivery system, a method of making a radium complexing compound, a method of extracting a radionuclide, and a method of delivering a radionuclide |
| 09/08/2000 | WO2000052031A2 Kit for radiolabeling proteins with yttrium-90 |
| 09/08/2000 | WO2000018212A9 Platelet-derived growth factor c, dna coding therefor, and uses thereof |
| 09/08/2000 | CA2742153A1 Method for radiolabeling a chelator-conjugated antibody with 111ln |
| 09/06/2000 | EP1032426A1 Therapeutic agents |
| 09/06/2000 | EP0641222B1 TECHNETIUM-99m LABELED PEPTIDES FOR THROMBUS IMAGING |
| 09/06/2000 | CN1265572A Method of imaging cell death in vivo |
| 09/05/2000 | US6113878 Scintigraphy |
| 09/05/2000 | US6113877 σ-2 receptors as biomarkers of tumor cell proliferation |
| 09/05/2000 | US6113875 Isotope-labelled urea and acid; ulcers |
| 09/05/2000 | CA2039399C Dual functioning excipient for metal chelate contrast agents |
| 08/31/2000 | WO2000050086A1 Molecules for the treatment and diagnosis of tumors |
| 08/30/2000 | CN1264601A Medicinal box of Re-188-rhenium sulfide suspension and its preparing process |
| 08/24/2000 | WO2000048639A1 Immobilized labeling compounds and methods |
| 08/24/2000 | WO2000018440A8 Somatostatin receptor radioligand with increased uptake |
| 08/24/2000 | CA2362860A1 Immobilized labeling compounds and methods |
| 08/23/2000 | EP1028781A1 $i(IN SITU)-GENERATED SOLID RADIATION SOURCE BASED ON TUNGSTEN?188 /RHENIUM?188 AND THE USE THEREOF |
| 08/23/2000 | EP1028758A1 Methods for treating prostate tumors using radioactive compositions |
| 08/23/2000 | EP1028757A1 Radioactive embolizing compositions |
| 08/23/2000 | EP1028756A1 Water soluble paclitaxel derivatives |
| 08/23/2000 | EP1028755A2 A method for the reduction of oxygenated compounds of rhenium or technetium |
| 08/23/2000 | EP1028754A1 Prevention of immunoreactivity by depleting or inhibiting antigen presenting cells |
| 08/23/2000 | EP0667859B1 Molecule labelling using 2-hydraninopyridine derivatives |
| 08/23/2000 | CN1055685C Heteroation-bearing ligands and metal complexes thereof |
| 08/22/2000 | US6107476 Nucleic acid molecule encoding a protein growth factor for inhibiting prostate cancer cell growth |
| 08/22/2000 | US6107459 Technetium-99m labeled peptides for diagnostic imaging |
| 08/22/2000 | US6107102 Therapeutic microdevices and methods of making and using same |
| 08/22/2000 | US6106840 Autoimmune diseases |
| 08/22/2000 | US6106804 Arsenic-72 labeled compounds for tissue specific medical imaging |
| 08/17/2000 | WO2000015231A9 Adenosine a3 receptor modulators |
| 08/16/2000 | EP1027365A2 Antitumour uridine analogues |
| 08/16/2000 | EP1027081A1 Intra-coronary radiation devices containing ce-144 or ru-106 |
| 08/16/2000 | EP1027080A1 Method for detection of fibrin clots |
| 08/16/2000 | EP1027079A1 Enhancement of delivery of radioimaging and radioprotective agents |
| 08/16/2000 | EP1027078A1 IMMUNIZATION AGAINST $i(STREPTOCOCCUS PNEUMONIAE) USING CONJUGATED AND UNCONJUGATED PNEUMOCOCCAL POLYSACCHARIDE VACCINES |
| 08/16/2000 | EP0703790B1 Iodinated paramagnetic chelates, and their use as contrast agents |
| 08/15/2000 | US6103725 High affinity to the dopamine d4 receptor; antagonists; antipsychotic agents, e.g. schizophrenia, with reduced side-effects; antipsychotic agents; anxiolytic and antiemetic agents; motoric functions, addiction, sleep, feeding |
| 08/15/2000 | US6103499 Inhibitors of human plasmin derived from the Kunitz domains |
| 08/15/2000 | US6103295 Method of affixing radioisotopes onto the surface of a device |
| 08/15/2000 | US6103216 Hepatocyte-selective oil-in-water emulsion |
| 08/15/2000 | CA2034484C Radioimmunotherapy using .alpha.-particles emission |
| 08/10/2000 | WO2000045892A1 Method for intravascular radiation therapy |
| 08/10/2000 | WO2000045858A1 Collagen-based delivery of radioactivity for use in brachytherapy |
| 08/10/2000 | WO2000045791A2 Method for controlling liposome size |
| 08/10/2000 | WO2000045627A2 Radioactive transition metal stents |
| 08/10/2000 | CA2361551A1 Method for controlling liposome size |
| 08/09/2000 | EP1024838A1 Stable radioiodine conjugates and methods for their synthesis |
| 08/09/2000 | EP0763056B1 Use of surfactants for stabilization of peptides and proteins for radiopharmaceutical use |
| 08/09/2000 | CN1262679A IL-5 inhibiting 6-azauracil derivatives |
| 08/09/2000 | CN1262619A Process for preparing reactive pharmaceutical product for detection of gastrointestinal disorder caused by bacteria |
| 08/08/2000 | US6099822 Comprising a complex formed between technetium (tc-99m) and 5-thio-d-glucose used in imaging of acute ischemic tissue and tumors |
| 08/08/2000 | US6099821 Nuclear scintigraphic assessment of mucosal function |
| 08/08/2000 | US6099457 Endocurietherapy |
| 08/08/2000 | CA2188133C Tin-117m-containing radiotherapeutic agents |
| 08/03/2000 | WO2000044746A1 Novel azabicyclo derivatives and their use |
| 08/03/2000 | WO2000044715A1 Novel aralkylguanidine compounds |
| 08/03/2000 | WO2000044682A1 Biodegradable glass compositions and methods for radiation therapy |
| 08/03/2000 | WO2000009076A9 Imaging with tc-99m labeled fibrin-alpha-chain peptide |
| 08/02/2000 | EP1023289A1 Dopamine transporter imaging ligand |
| 08/02/2000 | EP0630407B1 Anti-viral fusion peptides |
| 08/02/2000 | CN1261881A 6-azauracil derivatives as IL-5 inhibitors |
| 08/01/2000 | US6096726 Multicomponent complex for use with substrate |
| 08/01/2000 | US6096551 Methods for producing antibody libraries using universal or randomized immunoglobulin light chains |
| 08/01/2000 | US6096290 Radionuclide labeling of vitamin B12 and coenzymes thereof |
| 08/01/2000 | US6096289 Intraoperative, intravascular, and endoscopic tumor and lesion detection, biopsy and therapy |
| 08/01/2000 | US6096070 Coated implantable medical device |
| 07/27/2000 | WO2000043401A1 Boron steroid mimics and pharmaceutical compositions |
| 07/27/2000 | WO2000043045A1 Method for improved radiation therapy |
| 07/27/2000 | WO2000043004A1 1,4,8,11-tetraazacyclotetradecane derivatives as radiodiganostic agents and their use in determining hypoxia and radioresistance of tumors |
| 07/27/2000 | WO1999064033A9 Phosphodiesterase-v modulator drugs and their uses |
| 07/27/2000 | CA2361115A1 1,4,8,11-tetraazacyclotetradecane derivatives as radiodiganostic agents and their use in determining hypoxia and radioresistance of tumors |
| 07/27/2000 | CA2361064A1 Boron steroid mimics and pharmaceutical compositions |
| 07/27/2000 | CA2358989A1 Method for improved radiation therapy |